13 May 2008   |   News

CyDen raises £2.8M in third-round funding

Funding round completed

CyDen Ltd, a Swansea-based medical devices company and pioneer of intense pulsed light (IPL) technology, has raised £2.8 million in a third-round funding led by Longbow Capital LLP and supported by Unilever Ventures.

The company says its products, which offer light-based treatments for permanent hair reduction, acne, skin blemishes, pigmentation as well as phototherapy for anti-ageing and wrinkle reduction, are poised for growth following the completion of the round.

CyDen has miniaturised and simplified the power technology to provide small and portable IPL devices that deliver safe and effective results at lower energy levels than other forms of treatment.

Professor Marc Clement, Chairman of CyDen, said, “We are delighted that Unilever Ventures recognises both the immediate and future impact of CyDen in the professional and spa environment. Light therapy offers a tremendous opportunity for non-invasive cosmetic treatments and an alternative to traditional skin care remedies.”

Never miss an update from Science|Business:   Newsletter sign-up